01
Mission
The purpose is effective altruism: using evidence and careful reasoning to help others as much as possible. No impact is claimed.
Read the mission noteAI-Driven Investing
Orbiquant is currently paper trading only, uses no real capital, and is not accepting investors.
A proposed practice, centered on effective altruism.
Orbiquant is an early-stage concept for an AI-driven investment practice. The aim is a transparent practice with a purpose beyond the portfolio: a planned gift of 10% of realized profits to charities chosen using criteria we'll publish. No results yet.
- Paper trading only
- No real capital
- Not accepting investors
Contents of this note
Six notes. No signup. No offer.
What these notes say
03
Planned giving
The proposed commitment is 10% of realized profits to charities chosen using criteria we'll publish. It is not a donation record. No results yet.
Read the planned giving note05
Paper testing
The work under discussion is simulated. It is not real capital. No results yet.
Read the paper testing noteThe figures you will not find
Financial results and verified impact are reported on separate scorecards. No results yet. An empty cell is not a zero.
Simulation · Paper only · Not real capital
Simulation label: paper testing only. A hypothetical result is not realized actual profit. No results yet. No real capital is in use.
Hypothetical result
A hypothetical result would be a simulated outcome from paper testing. No results yet. It would not be realized profit.
No results yet.
Realized actual profit
Realized actual profit would be profit from real capital. No results yet. No real capital is in use.
No results yet.
Limits that apply to every page
Paper only
Activity described on this site is paper testing. There are no live investments. A hypothetical or simulated result, if one were later shown, would not be realized actual profit. No results yet.
Investment risk
Investing involves risk, including possible loss of principal. No return is promised, guaranteed, or projected on this site. Paper testing does not predict future results.
No solicitation
This website is not an offer to sell, and not a solicitation of an offer to buy, any security or other investment. Orbiquant is not accepting investors. This site does not accept subscriptions, allocation requests or capital commitments.